MWNA
TAK icon

Marshall Wace North America’s Takeda Pharmaceutical TAK Stock Holding History

Marshall Wace North America’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-336,601
Closed -$5.67M – 1709
2021
Q2 		$5.67M Buy
336,601
+224,602
+201% +$3.82M 0.02% 520
2021
Q1 		$2.04M Buy
111,999
+41,196
+58% +$741K 0.01% 820
2020
Q4 		$1.29M Sell
70,803
-663,207
-90% -$11.6M 0.01% 878
2020
Q3 		$13.1M Buy
734,010
+264,213
+56% +$4.81M 0.08% 240
2020
Q2 		$8.42M Buy
+469,797
New +$8.43M 0.06% 283
2020
Q1 		– Sell
-370,993
Closed -$7.32M – 1587
2019
Q4 		$7.32M Sell
370,993
-141,816
-28% -$2.71M 0.04% 334
2019
Q3 		$8.82M Buy
+512,809
New +$8.87M 0.05% 278

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return